Clinical Trials Browser

Not yet recruiting × Hematologic Neoplasms × Antilymphocyte Serum × Clear all

NCT06238245 2024-02-20

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Phase 2 Not yet recruiting

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms